Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

GE nabs U-Systems

GE Healthcare has acquired U-Systems, a manufacturer of ultrasound products designed for breast imaging. Financial terms were not disclosed.

False alarm: Perifissural nodules on CT are likely benign

Despite growth that typically represents malignancy, pulmonary perifissural nodules (PFNs) are almost certainly benign and likely represent lymph nodes, according to a study published in the November issue of Radiology.

Can proton beam remedy quality of life issues after prostate cancer treatment?

Patients who underwent proton beam therapy for prostate cancer reported higher quality of life in early follow-up and similar scores at two years, compared with 3D conformal therapy and intensity-modulated radiation therapy, according to research presented at the American Society for Radiation Oncology (ASTRO) annual meeting in Boston.

SBRT ups survival rates for inoperable lung cancer patients

Stereotactic body radiation therapy (SBRT) could offer patients with inoperable non-small cell lung cancer (NSCLC) higher overall survival rates with lower toxicity than conventional radiation therapy, according to research presented Oct. 29 at the American Society for Radiation Oncology (ASTRO) annual meeting in Boston.

AACR: Minorities less likely to receive radiotherapy

Women with aggressive breast cancer at diagnosis were more likely to receive chemotherapy, but at the expense of completing locoregional radiotherapy, according to data presented at the Fifth American Association for Cancer Research (AACR) Conference on The Science of Cancer Health Disparities in San Diego Oct. 27—30.

Prognostic test may help maximize lung CT screening benefits

A prognostic assay helps identify patients with high-risk T1a node-negative non-small-cell lung cancer, which may inform post-surgical treatment, according to a research letter published Oct. 23 in Journal of the American Medical Association.

Know the signs: Many pulmonary conditions mimic lung cancer

A variety of pulmonary conditions are characterized by imaging findings that mimic lung cancers, making them difficult to differentiate from cancer, according to an article published in the October issue of the American Journal of Roentgenology.

Oncology imaging: Status indeterminate

Oncology imaging is in a state of upheaval. Consider lung cancer screening. Early adopters, including the Veterans Affairs, are moving ahead with CT lung cancer screening. Yet, as the wheels of reimbursement inch forward, it seems apparent we are mired in muck.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.